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Book Reviews
Investigation and Stimulation of Immu-
nity in Cancer Patients. Ed. G. MATHEI
and R. WEINER (1974). Springer-Verlag:
Berlin, Heidelberg, New York. Pp. 501.
Price £18.24 net.
This volume consists of 73 papers em-
bracing several contemporary aspects of
cancer immunology. It is divided into
two parts: the investigation of non-specific
and specific immunity in cancer patients
and the stimulation of immunity in experi-
mental and clinical situations.
As is inevitable in a collection of papers
assembled for a major scientific meeting
there is relatively little material which is
original and cannot be gleaned from else-
where. Most authors, however, provide
a comprehensive bibliography and the chief
merit of the book is that it brings together
a considerable diversity of material between
the same covers. In this respect it serves
as a useful compendium of approaches and
ideas extant at the time of the meeting.
(Summer, 1972.) The gap between the
time of the meeting and appearance in
print in this instance is about 3 years and
it should be read with the awareness that
attitudes in some areas (e.g. in vitro testing
for specific tumour immunity) have since
changed decisively.
Certain contributions are undoubtedly
more worthwhile than others. Some are
written up as full papers with considerable
experimental detail and analyses of results.
Others, on the other hand, are very cursory
and/or highly speculative presentations.
These latter are of no intrinsic value as
scientific communications and simply add
useless padding to the literature explosion
in which the entire medico-scientific com-
munity is engulfed. Another category of
paper is technically naive and contains no
applied data, which hardly seems to justify
its appearance in this volume at all.
In several papers there appears to have
been already a critical awareness of the
multiplicity of problems associated with in
vitro and in vivo tests for tumour immunity
in man, which anticipated to some extent
the conclusions of more recent investigations.
The bulk of the text, however, is given over
to the effects of systemic bacterial adjuvants
which directly or indirectly feature in
almost two thirds of the communications.
This is perhaps not surprising, since Mathe
has been an energetic protagonist of their
deployment in the treatment of lympho-
reticular neoplasia. The interests of those
whose primary interests are in this field
will be well served by this useful, if now
somewhat outdated, resum6 of the state
of the art.
M. MOORE
Clinical Cancer Chemotherapy. EZRA M.
GREENSPAN (1975). New York: Raven
Press. Pp. 414. Price $16.50. Amster-
dam: North-Holland. Pp. 431. Price
$18.25.
A comprehensive knowledge and under-
standing of the indications for, and charac-
teristics of, any drug are important and
this applies particularly to the field of
cancer chemotherapy. The correct choice
of drug or drug combination may decide
the difference between success and failure.
It is essential therefore that clinicians in-
volved in the management of patients with
malignant disease have a working knowledge
of the drugs that they prescribe.
This multi-author volume is a compre-
hensive guide to cancer chemotherapy.
There are three introductory chapters; the
basis ofdrug combinations, molecular biology
and aspects of clinical pharmacology. This
is followed by individual chapters on all
the tumours falling within the range of the
chemotherapist. Detailed schedules are dis-
cussed, together with precautions and side
effects. In general, all are well written and
some of the illustrated figures provide an
excellent summary for revision purposes.
In some instances individual patient histories
are quoted which I feel detract from the
general high standard. Similarly, there is
a mixture of generic and proprietary names
given to many drugs and such a practice is
to be deprecated.
These facts apart, however, the general
standard is good. On many occasions, by
the time a text on cancer therapy is pub-BOOK REVIEWS 671
lished, the schedules listed have become
outdated. Here, however the authors are
to be congratulated on presenting regimens
in general, and combinations in particular,
that are currently in use at this moment.
The book will appeal to all involved in the
management of malignant disease and is
particularly recommended to those in junior
grades. It should provide a useful reference
to those in other disciplines and find a place
in medical libraries.
P. M. WILKINSON
Cancer of the Lung. H. G. SEYDEL,
A. CHAIT and J. T. GMELICH (1975).
New York: John Wiley & Sons. Price
£14.00 net.
This is another book on cancer of the
lung. It comes from the USA, is of multiple
authorship, and is well produced. The
authors have succeeded in their obvious
intention to review the subject comprehen-
sively yet compactly, and it is fair to say
that, as a presentation of known fact and
of contemporary North American opinion
and practice, it could hardly be improved.
The bibliography includes references up to
1974.
Subjects such as incidence, aetiology,
natural history, early detection, lymphatic
spread, staging, and associated medical
conditions each have a chapter to themselves,
and on the whole are competently reviewed,
though the section on endocrine manifesta-
tions could have been expanded, and
reference to the neuropathies is perfunctory.
The presentation of the chapter on staging
emphasizes the impractical complexity of
the UICC TNM classification, though the
proposed NCI classification is hardly better,
since it is based on the UICC system.
The discussion of pathology is full, de-
tailed and clear, and emphasizes the difficulty
of classification ofsuch pleomorphic tumours.
The contribution of diagnostic radiology is
also very well described, and a particularly
good feature of this chapter is the well-
balanced evaluation of the less common
procedures such as arteriography and veno-
graphy.
Chemotlherapy is allocatedI tw-ro pages
oftext, ancd, togetlher wi-itlh a page on imimnUniio-
therapy, forms a chapter titled ' Specific
Medical Management". Its brevity is sur-
44
prising in view of the enormous amount
of work done in the USA on chemotherapy,
and perhaps reflects disillusionment with
the very limited value of chemotherapy
for lung cancer. It seems that the general
conclusions to be drawn are that cyclo-
phosphamide used as a single agent for the
late case can be useful, that the slightly
greater effect of combination chemotherapy
is out-weighed by the greater toxicity, and
that chemotherapy in combination with
surgery or radiotherapy is of no value.
There has been no real progress in the
treatment of patients with lung cancer
for many years, and anyone with a special
interest in the disease approaches the
chapters on management with the hope of
finding something new which might en-
courage optimism. Sadly, overall survival
rates remain unchanged, though there has
certainly been a little progress, mainly
amongst surgeons, in a more precise know-
ledge of what radical treatment can achieve.
The relatively short chapter on surgical
treatment is perhaps the best part of the
book: it is succinct and authoritative.
There is now full awareness ofthe importance
of pre-operative staging, especially since
mediastinoscopy has become common, and
a realization that only " early " cases benefit
from resection. The result has been a
significant increase in survival rates for
patients undergoing resection, and a pro-
portionate decrease in the thoracotomy-only
figures. This does not mean, of course,
that more patients are being cured of cancer,
but it does mean that fewer patients have
an unnecessary thoracotoImy. The general
trend towards conservative resection is con-
firmed. It seems that the indications for
surgery, and the limits of its usefulness, are
now fairly well defined.
One might have expected that the
selection of cases for radical radiotherapy
with curative intent would have been
refined in the same way, but the opposite
seems to be true. The indications for
radical x-ray treatment include patients
with extensive mediastinal node involve-
ment, and even those with metastases in
the supraclavicular nodes. It seems that
treatment is relatively standardized to a
parallel pair of fields enclosing the primary
tumour and most of the mediastinumn. Field
sizes al-e not usually given, but judging by
the diagrams must be of the order of 15 x 10